Press coverage about Select Medical (NYSE:SEM) has been trending positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Select Medical earned a news impact score of 0.25 on Accern’s scale. Accern also assigned media headlines about the health services provider an impact score of 46.5829391111781 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:
- Health care a prime field for heart-and-soul-inspired leaders | David Yeghiaian (htrnews.com)
- Select Medical (SEM) Downgraded by Zacks Investment Research (americanbankingnews.com)
- Select Medical (SEM) Upgraded to Buy by Zacks Investment Research (americanbankingnews.com)
- BCI Pharma receives €3.9M ($4.7M) in public and private funding; sets up laboratory (pharmiweb.com)
Shares of Select Medical (NYSE:SEM) opened at $18.35 on Tuesday. The company has a debt-to-equity ratio of 2.87, a current ratio of 1.52 and a quick ratio of 1.52. The firm has a market capitalization of $2,494.33, a price-to-earnings ratio of 13.80, a price-to-earnings-growth ratio of 1.24 and a beta of 1.23. Select Medical has a twelve month low of $12.00 and a twelve month high of $19.77.
Select Medical (NYSE:SEM) last posted its earnings results on Wednesday, February 21st. The health services provider reported $0.31 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.19 by $0.12. The company had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.10 billion. Select Medical had a return on equity of 14.27% and a net margin of 3.99%. Select Medical’s revenue was up 6.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.12 earnings per share. equities research analysts forecast that Select Medical will post 1.07 EPS for the current fiscal year.
Several research firms have weighed in on SEM. Zacks Investment Research raised Select Medical from a “hold” rating to a “buy” rating and set a $21.00 target price on the stock in a report on Tuesday, March 13th. ValuEngine raised Select Medical from a “buy” rating to a “strong-buy” rating in a report on Thursday, March 1st. Robert W. Baird reissued a “buy” rating and issued a $26.00 target price on shares of Select Medical in a report on Friday, February 23rd. JMP Securities raised Select Medical from an “underperform” rating to a “market perform” rating and set a $12.00 target price on the stock in a report on Tuesday, February 27th. Finally, TheStreet raised Select Medical from a “c+” rating to a “b-” rating in a report on Thursday, March 1st. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $20.63.
In related news, insider Martin F. Jackson sold 134,029 shares of the stock in a transaction on Friday, December 22nd. The stock was sold at an average price of $17.05, for a total transaction of $2,285,194.45. Following the sale, the insider now owns 1,717,944 shares of the company’s stock, valued at $29,290,945.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Scott A. Romberger sold 5,000 shares of the stock in a transaction on Monday, February 26th. The shares were sold at an average price of $18.46, for a total value of $92,300.00. Following the sale, the insider now directly owns 167,811 shares in the company, valued at approximately $3,097,791.06. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 139,352 shares of company stock worth $2,383,002. Corporate insiders own 19.86% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Positive Press Coverage Somewhat Unlikely to Impact Select Medical (SEM) Stock Price” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://ledgergazette.com/2018/03/20/positive-press-coverage-somewhat-unlikely-to-impact-select-medical-sem-stock-price.html.
About Select Medical
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.